(Q72005655)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

A Struys

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

A A Snelder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

H Mulder

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 September 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

22 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

235-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Management of corticosteroid-induced osteoporosis: a clinician's perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

The effects of sex steroid and corticosteroid hormones on bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Differential effects of endocrine dysfunction on the axial and the appendicular skeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Bone loss in response to long-term glucocorticoid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Calcium supplements in the prevention of steroid-induced osteoporosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Salmon calcitonin in the therapy of corticoid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Two-year follow-up of biphosphonate (APD) treatment in steroid osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

A critical review of bone mass and the risk of fractures in osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Epidemiology of vertebral fractures in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Baseline measurement of bone mass predicts fracture in white women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Corticosteroid effects on proximal femur bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Steroid-induced fractures and bone loss in patients with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980154-5

10.1016/S0002-9343(99)80154-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653482%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference